Wegovy and anaesthesia guidelines: what to tell your surgical team

The night before surgery: why a normal fast may not be enough

Picture this. You've followed the instructions: nil by mouth from midnight, no breakfast, you arrive at the ward on time. But you're also on Wegovy, which you injected four days ago. The anaesthetist asks the standard questions and one stops them: are you on any injections or weight-loss medication?

The reason that question matters is straightforward. Semaglutide works partly by slowing the rate at which food moves from the stomach into the small intestine. In everyday life, that is exactly what you want — it keeps you feeling full for longer. In an operating theatre, it means the stomach may still contain food or liquid that a standard fast would normally have cleared. If stomach contents are present when you are put under general anaesthesia, there is a risk of aspiration: material entering the airway, which can cause serious lung injury.

This is not a theoretical concern. The Royal College of Anaesthetists and the Association of Anaesthetists have both flagged GLP-1 medicines in their guidance on perioperative management. NHS England's guidance on weight-management injections states plainly that patients should tell their healthcare team, including the anaesthetist, that they take one of these medicines before any surgical procedure. That advice applies whether your surgery is planned months ahead or arranged at short notice. You can read more about the broader clinical framework in our overview of semaglutide prescribing guidelines.

What the guidance actually recommends about stopping Wegovy before an operation

The honest answer is that there is no single universal stop date stamped into every protocol, the picture is still evolving as GLP-1 use has grown rapidly. What UK and international anaesthetic bodies generally advise is that for elective (planned) procedures, the surgical team should be told about GLP-1 use at the pre-operative assessment, and a decision about pausing the medicine should be made on an individual basis.

The approach many anaesthetic teams are using in practice draws on guidance that sets out how Wegovy should be prescribed and managed around procedures, alongside advice from the Association of Anaesthetists and, internationally, the American Society of Anesthesiologists. For once-weekly injectables like Wegovy, holding the dose for one week before elective surgery is commonly discussed, though some teams opt for longer pauses depending on the procedure, the patient's history, and current symptoms like nausea or vomiting. A longer pause (sometimes up to two or more weeks) may be considered for higher-risk procedures or patients with delayed gastric emptying symptoms.

The MHRA's safety communications for GLP-1 medicines reinforce the importance of clinical communication: reporting concerns and suspect effects is part of the wider pharmacovigilance picture. If you're managing your treatment through a private service and have surgery approaching, the right step is to contact both your prescriber and your anaesthetist so they can coordinate. If you'd like a closer look at how Wegovy interacts with anaesthesia and what that means for your care, we cover that in detail on a dedicated page. You can also find a fuller patient-level overview of what semaglutide is, how it works, and who it's suitable for if you want the broader context before speaking to your team.

Practical steps if you're on Wegovy and surgery is on the horizon

We know this situation can feel stressful, you've found something that's working, and now you're being asked to pause it right when the pressure of a procedure adds to everything else. That's a reasonable thing to find frustrating. Here is what actually helps.

First, tell everyone. At your pre-operative assessment, mention Wegovy by name, give the dose you're currently on, and the date of your last injection. Do not assume it's on your repeat-prescription record or that the GP has shared it. Tell the anaesthetist directly, and if you want to understand the specific risks they'll be considering, our page on semaglutide and anaesthesia explains the clinical reasoning in plain terms. Some patients carry a brief medication list to appointments for exactly this reason.

Second, contact your prescriber before the surgery, not after. At nume, every repeat is clinically reviewed before it's dispensed, so if surgery is approaching, let us know and one of our clinical team can advise on timing. Do not simply skip a dose without guidance: your prescriber needs to know so the plan is coordinated and restarting safely after surgery is managed properly too.

Third, once surgery is done and recovery is confirmed, discuss with your prescriber when to restart. Restarting too soon, particularly if your appetite and gut function haven't fully normalised, can increase nausea and complicate recovery. The restart is a clinical decision, not a calendar one. If you're still weighing up your options or want to understand what Wegovy treatment involves more broadly, our guide to Wegovy covers the full picture, and details of the cost of private treatment are on our treatment page. For anyone ready to have their situation reviewed by a prescriber, you can check your eligibility with us at any point.